AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 MAY 30 - (NewsRx.com & NewsRx.net) -- Digene Corp. (DIGE) announced that the United States Army is adopting testing for human papillomavirus (HPV), using the company's Hybrid Capture 2 (HC2) HPV DNA Test, in its worldwide cervical cancer screening program.
The U.S. Army is the first military service and the largest U.S. government employer to adopt HPV testing as a follow-up to borderline pap test results.
The U.S. Army conducts approximately 350,000-400,000 pap tests annually in its medical treatment facilities worldwide serving military personnel and their dependents. Studies show that between 5-7% of all pap smears conducted in the U.S. produce borderline results. The Army will use HPV testing to help determine ...
Source: HighBeam Research, Digene enters contract with U.S. Army for Hybrid Capture 2 HPV DNA...